Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 124

1.

Correction: Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery. Pharmaceutics, 2017, 9(3), 27.

Ono A, Ito S, Sakagami S, Asada H, Saito M, Quan YS, Kamiyama F, Hirobe S, Okada N.

Pharmaceutics. 2017 Dec 18;9(4). pii: E59. doi: 10.3390/pharmaceutics9040059.

2.

A case of panspinal epidural abscess that presented with meningeal irritation.

Okada N, Nishiyama T, Kurihara M, Nishimura Y, Nishimura Y, Ando Y, Otsubo S, Yamada K, Maeda Y.

Acute Med Surg. 2017 Jul 6;4(3):363-366. doi: 10.1002/ams2.294. eCollection 2017 Jul.

3.

Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.

Ono A, Azukizawa H, Ito S, Nakamura Y, Asada H, Quan YS, Kamiyama F, Katayama I, Hirobe S, Okada N.

Int J Pharm. 2017 Oct 30;532(1):374-383. doi: 10.1016/j.ijpharm.2017.08.110. Epub 2017 Aug 30.

PMID:
28855138
4.

Thermoelectric Properties of Poly(3-Hexylthiophene) Nanofiber Mat with a Large Void Fraction.

Hiura S, Okada N, Wakui J, Narita H, Kanehashi S, Shimomura T.

Materials (Basel). 2017 Apr 28;10(5). pii: E468. doi: 10.3390/ma10050468.

5.

Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery.

Ono A, Ito S, Sakagami S, Asada H, Saito M, Quan YS, Kamiyama F, Hirobe S, Okada N.

Pharmaceutics. 2017 Aug 3;9(3). pii: E27. doi: 10.3390/pharmaceutics9030027. Erratum in: Pharmaceutics. 2017 Dec 18;9(4):.

6.

DaMab-2: Anti-Human DGKα Monoclonal Antibody for Immunocytochemistry.

Nakano T, Ogasawara S, Tanaka T, Hozumi Y, Mizuno S, Satoh E, Sakane F, Okada N, Taketomi A, Honma R, Nakamura T, Saidoh N, Yanaka M, Itai S, Handa S, Chang YW, Yamada S, Kaneko MK, Kato Y, Goto K.

Monoclon Antib Immunodiagn Immunother. 2017 Aug;36(4):181-184. doi: 10.1089/mab.2017.0023. Epub 2017 Jul 25.

PMID:
28742439
7.

Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research.

Inoo K, Inagaki R, Fujiwara K, Sasawatari S, Kamigaki T, Nakagawa S, Okada N.

Mol Ther Oncolytics. 2016 Nov 16;3:16024. eCollection 2016.

8.

A Structurally Variable Porous Organic Salt Based on a Multidirectional Supramolecular Cluster.

Miyano T, Okada N, Nishida R, Yamamoto A, Hisaki I, Tohnai N.

Chemistry. 2016 Oct 17;22(43):15430-15436. doi: 10.1002/chem.201602233. Epub 2016 Sep 8.

PMID:
27607570
9.

Analysis of Skin Permeability and Toxicological Properties of Amorphous Silica Particles.

Matsuo K, Hirobe S, Okada N, Nakagawa S.

Biol Pharm Bull. 2016;39(7):1201-5. doi: 10.1248/bpb.b16-00258.

10.

Highly efficient gene transfer using a retroviral vector into murine T cells for preclinical chimeric antigen receptor-expressing T cell therapy.

Kusabuka H, Fujiwara K, Tokunaga Y, Hirobe S, Nakagawa S, Okada N.

Biochem Biophys Res Commun. 2016 Apr 22;473(1):73-79. doi: 10.1016/j.bbrc.2016.03.054. Epub 2016 Mar 15.

PMID:
26993168
11.

Clinical study of a retinoic acid-loaded microneedle patch for seborrheic keratosis or senile lentigo.

Hirobe S, Otsuka R, Iioka H, Quan YS, Kamiyama F, Asada H, Okada N, Nakagawa S.

Life Sci. 2017 Jan 1;168:24-27. doi: 10.1016/j.lfs.2015.12.051. Epub 2016 Jan 3.

PMID:
26757104
12.

Ventricular fibrillation by anaphylaxis following consumption of blue_skinned fish.

Otsubo S, Nishiyama T, Okada N, Ando Y, Yamada K, Maeda Y, Nishimura Y.

Acute Med Surg. 2015 Aug 12;3(2):159-162. doi: 10.1002/ams2.144. eCollection 2016 Apr.

13.

Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch.

Hirobe S, Azukizawa H, Hanafusa T, Matsuo K, Quan YS, Kamiyama F, Katayama I, Okada N, Nakagawa S.

Biomaterials. 2015 Jul;57:50-8. doi: 10.1016/j.biomaterials.2015.04.007. Epub 2015 Apr 24.

PMID:
25913250
14.

Radial and vertical distributions of radiocesium in tree stems of Pinus densiflora and Quercus serrata 1.5 y after the Fukushima nuclear disaster.

Ohashi S, Okada N, Tanaka A, Nakai W, Takano S.

J Environ Radioact. 2014 Aug;134:54-60. doi: 10.1016/j.jenvrad.2014.03.001. Epub 2014 Mar 22.

PMID:
24661964
15.

Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.

Matsuo K, Okamoto H, Kawai Y, Quan YS, Kamiyama F, Hirobe S, Okada N, Nakagawa S.

J Neuroimmunol. 2014 Jan 15;266(1-2):1-11. doi: 10.1016/j.jneuroim.2013.11.002. Epub 2013 Nov 11.

PMID:
24315156
16.

[From basic principles to clinical applications on transcutaneous vaccine].

Okada N.

Yakugaku Zasshi. 2013;133(12):1363-72. Review. Japanese.

17.

Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans.

Hiraishi Y, Hirobe S, Iioka H, Quan YS, Kamiyama F, Asada H, Okada N, Nakagawa S.

J Control Release. 2013 Oct 28;171(2):93-103. doi: 10.1016/j.jconrel.2013.06.008. Epub 2013 Jun 18.

PMID:
23791975
18.

Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.

Hirobe S, Azukizawa H, Matsuo K, Zhai Y, Quan YS, Kamiyama F, Suzuki H, Katayama I, Okada N, Nakagawa S.

Pharm Res. 2013 Oct;30(10):2664-74. doi: 10.1007/s11095-013-1092-6. Epub 2013 Jun 18.

PMID:
23775442
19.

Analysis of transcutaneous antigenic protein delivery by a hydrogel patch formulation.

Matsuo K, Ishii Y, Kawai Y, Saiba Y, Quan YS, Kamiyama F, Hirobe S, Okada N, Nakagawa S.

J Pharm Sci. 2013 Jun;102(6):1936-47. doi: 10.1002/jps.23540. Epub 2013 Apr 12.

PMID:
23585300
20.

Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery.

Matsuo K, Hirobe S, Okada N, Nakagawa S.

Vaccine. 2013 May 1;31(19):2403-15. doi: 10.1016/j.vaccine.2013.03.022. Epub 2013 Mar 21. Review.

PMID:
23523401

Supplemental Content

Loading ...
Support Center